Stemcentrx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 147

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.43B

Stemcentrx General Information

Description

Provider of cancer research and drug-development services designed to find a new approach to treat cancer. The company's services provide therapies to eliminate cancer stem cells, which initiate and perpetuate tumors, enabling healthcare providers to cure cancer of their patients and improve their lives.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 450 East Jamie Court
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 450 East Jamie Court
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stemcentrx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 01-Jun-2016 $6.43B Completed Clinical Trials - Phase 1
7. Later Stage VC (Series G) 14-Aug-2015 Completed Clinical Trials - Phase 1
6. Later Stage VC (Series F) 01-May-2014 Completed Clinical Trials - Phase 1
5. Later Stage VC 01-Apr-2013 Completed Generating Revenue
4. Later Stage VC (Series D) 01-Feb-2012 Completed Generating Revenue
3. Later Stage VC (Series C) 16-Mar-2011 Completed Generating Revenue
2. Early Stage VC (Series B) $3.25M $9.2M Completed Generating Revenue
1. Early Stage VC (Series A) $6M $6M Completed Generating Revenue
To view Stemcentrx’s complete valuation and funding history, request access »

Stemcentrx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series G
Series F2
Series F1
Series E
Series D
Series C
Series B
Series A2 88,191,172 $0.001000 8% $0.07 $0.07 1x $0.07
Series A1 88,191,172 $0.001000 8% $0.07 $0.07 1x $0.07 40.47%
To view Stemcentrx’s complete cap table history, request access »

Stemcentrx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of cancer research and drug-development services designed to find a new approach to treat cancer. The company's
Drug Discovery
South San Francisco, CA
147 As of 2016

San Francisco, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stemcentrx Competitors (46)

One of Stemcentrx’s 46 competitors is Pharmacyclics, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pharmacyclics Venture Capital-Backed San Francisco, CA
Endeavor BioMedicines Venture Capital-Backed San Diego, CA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 46 competitors. Get the full list »

Stemcentrx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stemcentrx Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
AME Cloud Ventures Venture Capital Minority
ARTIS (San Francisco) Venture Capital Minority
American Funds Insurance Series Government Minority
Bennu Venture Group Venture Capital Minority
Columbia Pacific Advisors Asset Manager Minority
You’re viewing 5 of 16 investors. Get the full list »

Stemcentrx FAQs

  • When was Stemcentrx founded?

    Stemcentrx was founded in 2008.

  • Where is Stemcentrx headquartered?

    Stemcentrx is headquartered in South San Francisco, CA.

  • What is the size of Stemcentrx?

    Stemcentrx has 147 total employees.

  • What industry is Stemcentrx in?

    Stemcentrx’s primary industry is Drug Discovery.

  • Is Stemcentrx a private or public company?

    Stemcentrx is a Private company.

  • What is the current valuation of Stemcentrx?

    The current valuation of Stemcentrx is .

  • What is Stemcentrx’s current revenue?

    The current revenue for Stemcentrx is .

  • How much funding has Stemcentrx raised over time?

    Stemcentrx has raised $552M.

  • Who are Stemcentrx’s investors?

    AME Cloud Ventures, ARTIS (San Francisco), American Funds Insurance Series, Bennu Venture Group, and Columbia Pacific Advisors are 5 of 16 investors who have invested in Stemcentrx.

  • Who are Stemcentrx’s competitors?

    Pharmacyclics, Endeavor BioMedicines, Aro Biotherapeutics, NGM Biopharmaceuticals, and Inovio Pharmaceuticals are some of the 46 competitors of Stemcentrx.

  • When was Stemcentrx acquired?

    Stemcentrx was acquired on 01-Jun-2016.

  • Who acquired Stemcentrx?

    Stemcentrx was acquired by AbbVie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process